Literature DB >> 26448412

Hepatic Sarcoidosis: Clinico-pathological characterization of symptomatic cases.

C Bihari, A Rastogi, N Kumar, S Rajesh, S K Sarin.   

Abstract

AIM: The aim of this study was to investigate the clinical and pathological features of hepatic sarcoidosis in symptomatic cases.
METHODS: Twenty-two symptomatic hepatic sarcoidosis cases were included in the study. Hepatic sarcoidosis was determined by typical imaging, histopathology, and high angiotensin-converting enzyme levels. Demographic data, laboratory data, imaging findings, liver biopsies, and clinical findings were analyzed. Portal hypertension (PH) was defined by the presence of ascites and/or varices; imaging findings suggestive of PH-splenomegaly (> 12 cm on longest axis); portal vein dilation (> 13 mm); collateral vessel formation; and hepatic venous pressure gradient ≥ 6 mmHg.
RESULTS: Mean age was 49.63 ± 10.7 years. Liver tests showed elevated serum alkaline phosphatase and gamma-glutamyl transpeptidase levels (95%). Serum albumin levels were low (< 3 g/dl) in 32% of the patients. Histologically, hepatic granulomas were located in the portal/periportal areas, with or without parenchymal involvement (77%). Duct damage (27%), absent portal veins (32%), and hepatomegaly (41%) were also observed. Clinically, chronic cholestatic symptoms and PH features were observed in 41% and 50% of the patients, respectively. Three-quarters of patients with PH features were non-cirrhotic. Cirrhosis and bleeding varices were observed in 14%. Hepatic sarcoidosis overlaps with primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC) was observed in two cases.
CONCLUSIONS: Sarcoidosis causes significant hepatic disease. PH and jaundice are main clinical presentations in liver sarcoidosis patients. Imaging findings of PH should be carefully reviewed, as it can occur even before the establishment of cirrhosis. Hepatic sarcoidosis mimics and overlaps with PBC and PSC. © Acta Gastro-Enterologica Belgica.

Entities:  

Year:  2015        PMID: 26448412

Source DB:  PubMed          Journal:  Acta Gastroenterol Belg        ISSN: 1784-3227            Impact factor:   1.316


  7 in total

1.  Clinical Characteristics and Outcome of Hepatic Sarcoidosis: A Population-Based Study 1976-2013.

Authors:  Patompong Ungprasert; Cynthia S Crowson; Douglas A Simonetto; Eric L Matteson
Journal:  Am J Gastroenterol       Date:  2017-09-05       Impact factor: 10.864

2.  Primary hepatic sarcoidosis presenting with cholestatic liver disease and mimicking primary biliary cholangitis: a case report.

Authors:  Young Joo Park; Hyun Young Woo; Moon Bum Kim; Jihyun Ahn; Jeong Heo
Journal:  J Yeungnam Med Sci       Date:  2021-08-10

3.  Granulomatous hepatitis in a patient with Crohn's disease and cholestasis.

Authors:  Bogdan Ioannis Patedakis Litvinov; Amit P Pathak
Journal:  BMJ Case Rep       Date:  2017-09-07

Review 4.  Clinical Manifestations, Diagnosis, and Treatment of Sarcoidosis.

Authors:  Patompong Ungprasert; Jay H Ryu; Eric L Matteson
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2019-08-02

5.  Hepatic Sarcoidosis: Natural History and Management Implications.

Authors:  Mai Sedki; Nicholas Fonseca; Priscila Santiago; Liege Diaz; Monica Garcia-Buitrago; Mehdi Mirsaeidi; Cynthia Levy
Journal:  Front Med (Lausanne)       Date:  2019-10-30

6.  Hepatic sarcoidosis: Clinical characteristics and outcome.

Authors:  Christiana Graf; Jeannette Arncken; Christian M Lange; Katharina Willuweit; Jörn M Schattenberg; Jessica Seessle; Julia Lang-Meli; Tobias Böttler; Julia Dietz; Nils Wetzstein; Antonia Mondorf; Johannes Vermehren; Gernot Rohde; Stefan Zeuzem; Anita Pathil
Journal:  JHEP Rep       Date:  2021-09-03

Review 7.  Sarcoidosis: A Clinical Overview from Symptoms to Diagnosis.

Authors:  Pascal Sève; Yves Pacheco; François Durupt; Yvan Jamilloux; Mathieu Gerfaud-Valentin; Sylvie Isaac; Loïc Boussel; Alain Calender; Géraldine Androdias; Dominique Valeyre; Thomas El Jammal
Journal:  Cells       Date:  2021-03-31       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.